108
Participants
Start Date
February 29, 2012
Primary Completion Date
August 31, 2016
Study Completion Date
January 31, 2018
letrozole
MRI
conventional surgery
Delaware Clinical and Laboratory Physicians PA, Newark
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
Regional Hematology and Oncology PA, Newark
Christiana Care Health System-Christiana Hospital, Newark
Northwest Hospital Center, Randallstown
Sentara Leigh Hospital, Norfolk
Sentara Hospitals, Norfolk
Sentara Cancer Institute at Sentara CarePlex Hospital, Hampton
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Margaret R Pardee Memorial Hospital, Hendersonville
Medical University of South Carolina, Charleston
Baptist Health Lexington, Lexington
Saint Elizabeth Medical Center South, Edgewood
Saint Elizabeth Fort Thomas, Fort Thomas
Ohio State University Comprehensive Cancer Center, Columbus
Riverside Methodist Hospital, Columbus
Grant Medical Center, Columbus
Southern Ohio Medical Center, Portsmouth
Sparrow Hospital, Lansing
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Mayo Clinic Cancer Center, Rochester
Missouri Baptist Medical Center, St Louis
Saint Luke's Hospital of Kansas City, Kansas City
University of Oklahoma Health Sciences Center, Oklahoma City
M. D. Anderson Cancer Center, Houston
Exempla Saint Joseph Hospital, Denver
Cedars Sinai Medical Center, Los Angeles
UCSF Medical Center-Mount Zion, San Francisco
Bay Area Tumor Institute, Oakland
Dana Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER